Skip to main content Accessibility help
×
Home
  • Print publication year: 2012
  • Online publication date: August 2012

Chapter 17 - Androgen therapy in non-gonadal disease

17.16 References

AaseboU, GyltnesA, BremnesRM, AakvaagA, SlordalL (1993) Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long term oxygen therapy. J Steroid Biochem Mol Biol 46:799–803
AhnYS, HarringtonWJ, SimonSR, MylvaganamR, PallLM, SoAG (1983) Danazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med 308:1396–1399
AloiJA, BergendahlM, IranmaneshA, VeldhuisJD (1997) Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal weight men. J Clin Endocrinol Metab 82:1543–1548
AltschuleMD, TillotsonKJ (1948) The use of testosterone in the treatment of depressions. N Engl J Med 239:1036–1038
AmbrizR, PizzutoJ, MoralesM, ChavezG, GuillenC, AvilesA (1986) Therapeutic effect of danazol on metrorrhagia in patients with idiopathic thrombocyotpenic purpura (ITP). Nouv Rev Fr Hematol 28:275–279
AmiazR, PopeHG, MahneT, KellyJF, BrennanBP, KanayamaG, WeiserM, HudsonJI, SeidmanSN (2011) Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther 37:243–254
AmoryJK, ChanskyHA, ChanskyKL, CamusoMR, HoeyCT, AnawaltBD, MatsumotoAM, BremnerWJ (2002) Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery. J Am Geriatr Soc 50:1698–1701
AndersonFH, FrancisRM, PeastonRT, WastellHJ (1997) Androgen supplementation in eugonadal men with osteoporosis: effects of six months treatment on bone formation and resorption. J Bone Miner Res 12:472–478
AntusB, YaoY, LiuS, SongE, LutzJ, HeemannU (2001) Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone. Kidney Int 60:1955–1963
AntusB, YaoY, SongE, LiuS, LutzJ, HeemannU (2002) Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Transpl Int 15:494–501
AtkinsonRA, Srinivas-ShankarU, RobertsSA, ConnollyMJ, AdamsJE, OldhamJA, WuFC, SeynnesOR, StewartCE, MaganarisCN, NariciMV (2010) Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly men. J Gerontol A Biol Sci Med Sci 65:1215–1219
BachmanE, FengR, TravisonT, LiM, OlbinaG, OstlandV, UlloorJ, ZhangA, BasariaS, GanzT, WestermanM, BhasinS (2010) Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 95:4743–4747
BacigalupoA, ChapleM, HowsJ, Van LintMT, McCannS, MilliganD, ChessellsJ, GoldstoneAH, OttolanderJ, van't VeerET, ComottiB, CoserP, BrocciaG, BosiA, LocasciulliA, CatalanoL, BattistaR, ArceseW, CarotenutoM, MarmontAM, Gordon SmithEC (1993) Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party. Br J Haematol 83:145–151
BakhshiV, ElliottM, GentiliA, GodschalkM, MulliganT (2000) Testosterone improves rehabilitation outcomes in ill older men. J Am Geriatr Soc 48:550–553
BallalSH, DomotoDT, PolackDC, MarciulonisP, MartinKJ (1991) Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease. Am J Kidney Dis 17:29–33
BanerjiA, SloaneDE, ShefferAL (2008) Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 100 (1 Suppl 2):S19–S22
BatterhamMJ, GarsiaR (2001) A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss. Int J Androl 24:232–240
BelchJJ, MadhokR, McArdleB, McLaughlinK, KluftC, ForbesCD, SturrockR (1986) The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol. Q J Med 58:19–27
BergerJR, PallL, HallCD, SimpsonDM (1996) Oxandrolone in AIDS-wasting myopathy. AIDS 10:1657–1662
BernsJS, RudnickMR, CohenRM (1992) A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. Clin Nephrol 37:264–267
BhasinS, StorerTW, Asbel-SethiN, KilbourneA, HaysR, Sinha-HikimI, ShenR, ArverS, BeallG (1998) Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab 83:3155–3162
BhasinS, WoodhouseL, CasaburiR, SinghAB, BhasinD, BermanN, ChenX, YarasheskiKE, MaglianoL, DzekovC, DzekovJ, BrossR, PhillipsJ, Sinha-HikimI, ShenR, StorerTW (2001) Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281: E1172–E1181
BhasinS, ParkerRA, SattlerF, HaubrichR, AlstonB, UmblejaT, ShikumaCM (2007) Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity. J Clin Endocrinol Metab 92:1049–1057
BlameySL, GardenOJ, ShenkinA, CarterDC (1984) Modification of postoperative nitrogen balance with preoperative anabolic steroid. Clin Nutr 2:187–192
BojesenA, JuulS, BirkebaekN, GravholtCH (2004) Increased mortality in Klinefelter syndrome. J Clin Endocrinol Metab 89:3830–3834
BonkovskyHL, FiellinDA, SmithGS, SlakerDP, SimonD, GalambosJT (1991) A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. Am J Gastroenterol 86:1200–1208
BooijA, Biewenga-BooijCM, Huber-BruningO, CornelisC, JacobsJW, BijlsmaJW (1996) Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis 55:811–815
BorkK, BygumA, HardtJ (2008) Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann Allergy Asthma Immunol 100:153–161
BrandaRF, AmsdenTW, JacobHS (1977) Randomized study of nandrolone therapy for anemia due to bone marrow failure. Arch Intern Med 137:65–69
BrockenbroughAT, DittrichMO, PageST, SmithT, StivelmanJC, BremnerWJ (2006) Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease. Am J Kidney Dis 47:251–262
BrubakerLH, BriereJ, LaszloJ, KrautE, LandawSA, PetersonP, GoldbergJ, DonovanP (1982) Treatment of anemia in myeloproliferative disorders: a randomized study of fluoxymesterone v transfusions only. Arch Intern Med 142:1533–1537
BuchwaldD, ArgyresS, EasterlingRE, OelshlegelFJ Jr, BrewerGJ, SchoomakerEB, AbbrechtPH, WilliamsGW, WellerJM (1977) Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients. Nephron 18:232–238
BulgerEM, JurkovichGJ, FarverCL, KlotzP, MaierRV (2004) Oxandrolone does not improve outcome of ventilator dependent surgical patients. Ann Surg 240:472–478; discussion:478–480
CamittaBM, ThomasED, NathanDG, GaleRP, KopeckyKJ, RappeportJM, SantosG, Gordon-SmithEC, StorbR (1979) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53:504–514
CasaburiR, BhasinS, CosentinoL, PorszaszJ, SomfayA, LewisMI, FournierM, StorerTW (2004) Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170:870–878
ChamplinRE, HoWG, FeigSA, WinstonDJ, LenarskyC, GaleRP (1985) Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial. Blood 66:184–188
ChanPCK, WeiDCC, TamSCF, ChanFL, YeungWC, ChengIKP (1992) Post-transplant erythrocytosis: role of erythropoietin and male sex hormones. Nephrol Dial Transpl 7:137–142
CherrierMM (2009) Testosterone effects on cognition in health and disease. Front Horm Res 37:150–162
CherrierMM, AsthanaS, PlymateS, BakerL, MatsumotoAM, PeskindE, RaskindMA, BrodkinK, BremnerW, PetrovaA, LaTendresseS, CraftS (2001) Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 57:80–88
CherrierMM, CraftS, MatsumotoAH (2003) Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. J Androl 24:568–576
CherrierMM, PlymateS, MohanS, AsthanaS, MatsumotoAM, BremnerW, PeskindE, RaskindM, LatendresseS, HaleyAP, CraftS (2004) Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men. Psychoneuroendocrinology 29:65–82
CherrierMM, MatsumotoAM, AmoryJK, AhmedS, BremnerW, PeskindER, RaskindMA, JohnsonM, CraftS (2005a) The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology 64:290–296
CherrierMM, MatsumotoAM, AmoryJK, AsthanaS, BremnerW, PeskindER, RaskindMA, CraftS (2005b) Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 64:2063–2068
ChlebowskiRT, HerroldJ, AliI, OktayE, ChlebowskiJS, PonceAT, HeberD, BlockJB (1986) Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer. Cancer 58:183–186
ChoiJB, LoredoJS, NormanD, MillsPJ, Ancoli-IsraelS, ZieglerMG, DimsdaleJE (2006) Does obstructive sleep apnea increase hematocrit?Sleep Breath 10:155–160
CicardiM, CastelliR, ZingaleLC, AgostoniA (1997) Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 99:194–196
ConwayAJ, BoylanLM, HoweC, RossG, HandelsmanDJ (1988) A randomised clinical trial of testosterone replacement therapy in hypogonadal men. Int J Androl 11:247–264
CoodleyGO, CoodleyMK (1997) A trial of testosterone therapy for HIV-associated weight loss. AIDS 11:1347–1352
Cooperative Group for the Study of Aplastic and Refractory Anaemias (1979) Androgen therapy of aplastic anaemia: a prospective study of 352 cases. Scand J Haematol 22:343–356
Copenhagen Study Group for Liver Diseases (1986) Testosterone treatment of men with alcoholic cirrhosis: a double-blind study. Hepatology 6:807–813
CoronaG, MonamiM, RastrelliG, AversaA, TishovaY, SaadF, LenziA, FortiG, MannucciE, MaggiM (2011a) Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 8:272–283
CoronaG, MonamiM, RastrelliG, AversaA, SforzaA, LenziA, FortiG, MannucciE, MaggiM (2011b) Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl 34:528–540
Coronary Drug Project Research Group (1973) The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. JAMA 226:652–657
CraigTJ (2008) Appraisal of danazol prophylaxis for hereditary angioedema. Allergy Asthma Proc 29:225–231
CrawfordBA, LiuPY, KeanM, BleaselJ, HandelsmanDJ (2003) Randomised, placebo-controlled trial of androgen effects on bone and muscle in men requiring long-term systemic glucocorticoid therapy. J Clin Endocrinol Metab 88:3167–3176
CreutzbergEC, WoutersEF, MostertR, PluymersRJ, ScholsAM (2003) A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 124:1733–1742
CutoloM, BalleariE, GiustiM, IntraE, AccardoS (1991) Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 34:1–5
DaniellHW (2006) Erythropoietin resistance during androgen deficiency. Arch Intern Med 166:1923; author reply:1923–1924
DarntonSJ, ZgainskiB, GrenierI, AllisterK, HillerL, McManusKG, SteynRS (1999) The use of an anabolic steroid (nandrolone decanoate) to improve nutritional status after esophageal resection for carcinoma. Dis Esophagus 12:283–288
DemlingRH (1999) Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns 25:215–221
DemlingRH, OrgillDP (2000) The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care 15:12–17
DiskinCJ (2007) Erythropoietin levels and androgens use: what is their relationship in the correction of anemia?Arch Intern Med 167:309
DobsAS, CofrancescoJ, NoltenWE, DanoffA, AndersonR, HamiltonCD, FeinbergJ, SeekinsD, YangcoB, RhameF (1999) The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection. Am J Med 107:126–132
DontasAS, PapanicolaouNT, PapanayiotouP, MalamosBK (1967) Long-term effects of anabolic steroids on renal functions in the aged subject. J Gerontol 22:268–273
DrinkaPJ, JochenAL, CuisinierM, BloomR, RudmanI, RudmanD (1995) Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels. J Am Geriatr Soc 43:899–901
DrososAA, van Vliet-DascalopoulosE, AndonopoulosAP, GalanopoulouV, SkopouliFN, MoutsopoulosHM (1988) Nandrolone decanoate (deca-durabolin) in primary Sjogren's syndrome: a double blind study. Clin Exp Rheumatol 6:53–57
DubowitzV, KinaliM, MainM, MercuriE, MuntoniF (2002) Remission of clinical signs in early Duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy. Eur J Paediatr Neurol 6:153–159
DuncanS, TalbotA, SheldrickR, CaswellH (2009) Erectile function, sexual desire, and psychological well-being in men with epilepsyEpilepsy Behav 15:351–357
EliasA, KumarA (2007) Testosterone for schizophrenia. Cochrane Database Syst Rev 3:CD006197
El-SadrA, SabryAA, Abdel-RahmanM, El-BarnachawyR, KoraitimM (1990) Treatment of primary nocturnal enuresis by oral androgen mesterolone. A clinical and cystometric study. Urology 36:331–335
EvansJT, EliasEG (1972) The erythropoietic response to anabolic therapy in patients receiving radiotherapy. J Clin Pharmacol New Drugs 12:101–104
EybenFE, GraugaardC, VaethM (2005) All-cause mortality and mortality of myocardial infarction for 989 legally castrated men. Eur J Epidemiol 20:863–869
EymanRK, GrossmanHJ, ChaneyRH, CallTL (1990) The life expectancy of profoundly handicapped people with mental retardation. N Engl J Med 323:584–589
FairfieldWP, TreatM, RosenthalDI, FronteraW, StanleyT, CorcoranC, CostelloM, ParlmanK, SchoenfeldD, KlibanskiA, GrinspoonS (2001) Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting. J Appl Physiol 90:2166–2171
FenichelG, PestronkA, FlorenceJ, RobisonV, HemeltVM (1997) A beneficial effect of oxandrolone in the treatment of Duchenne muscular dystrophy: a pilot study. Neurology 48:1225–1226
FenichelGM, GriggsRC, KisselJ, KramerTI, MendellJR, MoxleyRT, PestronkA, ShengK, FlorenceJ, KingWM, PandyaS, RobisonVD, WangH (2001) A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy. Neurology 56:1075–1079
FensterLF (1966) The nonefficacy of short-term anabolic steroid therapy in alcoholic liver disease. Ann Intern Med 65:738–744
FerreiraIM, VerreschiIT, NeryLE, GoldsteinRS, ZamelN, BrooksD, JardimJR (1998) The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 114:19–28
FinferS, ChittockDR, SuSY, BlairD, FosterD, DhingraV, BellomoR, CookD, DodekP, HendersonWR, HebertPC, HeritierS, HeylandDK, McArthurC, McDonaldE, MitchellI, MyburghJA, NortonR, PotterJ, RobinsonBG, RoncoJJ (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297
FrankeWW, BerendonkB (1997) Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 43:1262–1279
French Cooperative Group for the Study of Aplastic and Refractory Anaemias (1986) Androgen therapy in aplastic anaemia: a comparative study of high and low-doses and of 4 different androgens. Scand J Haematol 36:346–352
FürederW, ValentP (2011) Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches. Leuk Lymphoma 52:1435–1445
FustG, FarkasH, CsukaD, VargaL, BorkK (2011) Long-term efficacy of danazol treatment in hereditary angioedema. Eur J Clin Invest 41:256–262
GasconA, BelvisJJ, BerisaF, IglesiasE, EstopinanV, TeruelJL (1999) Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis. Geriatr Nephrol Urol 9:67–72
GaughanWJ, LissKA, DunnSR, MangoldAM, BuhsmerJP, MichaelB, BurkeJF (1997) A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Am J Kidney Dis 30:495–500
GauglitzGG, WilliamsFN, HerndonDN, JeschkeMG (2011) Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs?Curr Opin Clin Nutr Metab Care 14:176–181
GelfandJA, SherinsRJ, AllingDW, FrankMM (1976) Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities. N Engl J Med 295:1444–1448
GervasioJM, DickersonRN, SwearingenJ, YatesME, YuenC, FabianTC, CroceMA, BrownRO (2000) Oxandrolone in trauma patients. Pharmacotherapy 20:1328–1334
GilliverSC, RuckshanthiJP, HardmanMJ, NakayamaT, AshcroftGS (2008) Sex dimorphism in wound healing: the roles of sex steroids and macrophage migration inhibitory factor. Endocrinology 149:5747–5757
GilliverSC, RuckshanthiJP, HardmanMJ, ZeefLA, AshcroftGS (2009) 5alpha-dihydrotestosterone (DHT) retards wound closure by inhibiting re-epithelialization. J Pathol 217:73–82
GluudC, BennettP, DietrichsonO, JohnsenSG, RanekL, SvendsenLB, JuhlE (1981) Short-term parenteral and peroral testosterone administration in men with alcoholic cirrhosis. Scand J Gastroenterol 16:749–755
GluudC, DejgardA, BennettP, SvenstrupB (1987) Androgens and oestrogens before and following oral testosterone administration in male patients with and without alcoholic cirrhosis. Acta Endocrinol (Copenh) 115:385–391
GluudC, BennettP, SvenstrupB, MicicS, Copenhagen Study Group for Liver Diseases (1988) Effect of oral testosterone treatment on serum concentrations of sex steroids, gonadotrophins and prolactin in alcoholic cirrhotic men. Aliment Pharmacol Ther 2:119–128
GoldJ, BatterhamMJ, RekersH, HarmsMK, GeurtsTB, HelmyrPM, Silva de MendoncaJ, Falleiros CarvalhoLH, PanosG, PincheraA, AiutiF, LeeC, HorbanA, GatellJ, PhanuphakP, PrasithsirikulW, GazzardB, BlochM, DannerSA (2006) Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Med 7:146–155
GordonC, WallaceDJ, ShinadaS, KalunianKC, ForbessL, BraunsteinGD, WeismanMH (2008) Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus. Rheumatology (Oxford) 47:334–338
GoreCJ, ClarkSA, SaundersPU (2007) Nonhematological mechanisms of improved sea-level performance after hypoxic exposure. Med Sci Sports Exerc 39:1600–1609
GrayPB, SinghAB, WoodhouseLJ, StorerTW, CasaburiR, DzekovJ, DzekovC, Sinha-HikimI, BhasinS (2005) Dose-dependent effects of testosterone on sexual function, mood and visuospatial cognition in older men. J Clin Endocrinol Metab 90:3838–3846
GriggsRC, KingstonW, HerrBE, ForbesG, MoxleyRT (1985) Lack of relationship of hypogonadism to muscle wasting in myotonic dystrophy. Arch Neurol 42:881–885
GriggsRC, PandyaS, FlorenceJM, BrookeMH, KingstonW, MillerJP, ChutkowJ, HerrBE, MoxleyRT (1989) Randomized controlled trial of testosterone in myotonic dystrophy. Neurology 39:219–222
GrinspoonS, CorcoranC, AskariH, SchoenfeldD, WolfL, BurrowsB, WalshM, HaydenD, ParlmanK, AndersonE, BasgozN, KlibanskiA (1998) Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 129:18–26
GrinspoonS, CorcoranC, AndersonE, HubbardJ, StanleyT, BasgozN, KlibanskiA (1999) Sustained anabolic effects of long-term androgen administration in men with AIDS wasting. Clin Infect Dis 28:634–636
GrinspoonS, CorcoranC, ParlmanK, CostelloM, RosenthalD, AndersonE, StanleyT, SchoenfeldD, BurrowsB, HaydenD, BasgozN, KlibanskiA (2000) Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 133:348–355
GrunfeldC, FeingoldKR (1992) Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 327:329–337
GrunsteinRR, HandelsmanDJ, LawrenceSJ, BlackwellC, CatersonID, SullivanCE (1989) Hypothalamic dysfunction in sleep apnea: reversal by nasal continuous positive airways pressure. J Clin Endocrinol Metab 68:352–358
GucalpA, TrainaTA (2010) Triple-negative breast cancer: role of the androgen receptor. Cancer J 16:62–65
HajjarRR, KaiserFE, MorleyJE (1997) Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin EndocrinolMetab 82:3793–3796
HallGM, LarbreJP, SpectorTD, PerryLA, SilvaJAD (1996) A randomized trial of testosterone therapy in males with rheumatoid arthritis. Br J Rheumatol 35:568–573
HamdyRC, MooreSW, WhalenKE, LandyC (1998) Nandrolone decanoate for men with osteoporosis. Am J Ther 5:89–95
HamiltonJB (1937) Treatment of sexual underdevelopment with synthetic male hormone substance. Endocrinology 21:649–654
HamiltonJB, MestlerGE (1969) Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population. J Gerontol 24:395–411
HandelsmanDJ (1985) Hypothalamic-pituitary gonadal dysfunction in chronic renal failure, dialysis, and renal transplantation. Endocr Rev 6:151–182
HandelsmanDJ (2010a) Testicular dysfunction in systemic diseases. In: NieschlagE, BehreHM, NieschlagS (eds) Andrology. Male Reproductive Health and Dysfunction, 3rd edn. Springer-Verlag, Berlin, pp 339–364
HandelsmanDJ (2010b) Inadequate masking of testosterone. J Am Coll Cardiol 55:2290; author reply:2290–2291
HandelsmanDJ (2011) Commentary: androgens and “anabolic steroids”: the one-headed Janus. Endocrinology 152:1752–1754
HandelsmanDJ, DongQ (1993) Hypothalamo-pituitary gonadal axis in chronic renal failure. Endocrinol Metab Clin North Am 22:145–161
HandelsmanDJ, LiuPY (1998) Androgen therapy in chronic renal failure. Baillieres Clin Endocrinol Metab 12:485–500
HandelsmanDJ, MackeyMA, HoweC, TurnerL, ConwayAJ (1997) Analysis of testosterone implants for androgen replacement therapy. Clin Endocrinol (Oxf) 47:311–316
HansellDT, DaviesJW, ShenkinA, GardenOJ, BurnsHJ, CarterDC (1989) The effects of an anabolic steroid and peripherally administered intravenous nutrition in the early postoperative period. J Parenter Enter 13:349–358
HarenMT, WittertGA, ChapmanIM, CoatesP, MorleyJE (2005) Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas 50:124–133
HartkampA, GeenenR, GodaertGL, BootsmaH, KruizeAA, BijlsmaJW, DerksenRH (2008) Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren syndrome: a randomised controlled trial. Ann Rheum Dis 67:91–97
HartkampA, GeenenR, GodaertGL, BijlM, BijlsmaJW, DerksenRH (2010) Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. Ann Rheum Dis 69:1144–1147
HausmannDF, NutzV, RommelsheimK, CaspariR, MosebachKO (1990) Anabolic steroids in polytrauma patients. Influence on renal nitrogen and amino acid losses: a double-blind study. J Parenter Enter 14:111–114
HazeltonRA, McCrudenAB, SturrockRD, StimsonWH (1983) Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19-nortestosterone. Ann Rheum Dis 42:155–157
HendlerED, GoffinetJA, RossS, LongneckerRE, BakovicV (1974) Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. N Engl J Med 291:1046–1051
HerzogAG, KleinP, JacobsAR (1998) Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology 50:782–784
HerzogAG, FarinaEL, DrislaneFW, SchomerDL, SmithsonSD, FowlerKM, DworetzkyBA, BromfieldEB (2010) A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism. Epilepsy Behav 7:264–271
HonkanenL, LesserGT (2001) Testosterone use for rehabilitation of older men. J Am Geriatr Soc 49:339–340
HorlWH (1999) Is there a role for adjuvant therapy in patients being treated with epoetin?Nephrol Dial Transpl 14:50–60
HoseaSW, SantaellaML, BrownEJ, BergerM, KatushaK, FrankMM (1980) Long-term therapy of hereditary angioedema with danazol. Ann Intern Med 93:809–812
HosseinimehrSJ, ZakaryaeeV, FroughizadehM (2006) Oral oxymetholone reduces mortality induced by gamma irradiation in mice through stimulation of hematopoietic cells. Mol Cell Biochem 287:193–199
HowellSJ, RadfordJA, SmetsEM, ShaletSM (2000) Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction. Br J Cancer 82:789–793
HowellSJ, RadfordJA, AdamsJE, SmetsEM, WarburtonR, ShaletSM (2001) Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clin Endocrinol (Oxf) 55:315–324
IdanA, GriffithsKA, HarwoodDT, SeibelMJ, TurnerL, ConwayAJ, HandelsmanDJ (2010) Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial. Ann Intern Med 153:621–632
InkovaaraJ, GothoniG, HalttulaR, HeikinheimoR, TokolaO (1983) Calcium, vitamin D and anabolic steroid in treatment of aged bones: double-blind placebo-controlled long-term clinical trial. Age Ageing 12:124–130
IpFF, di PierroI, BrownR, CunninghamI, HandelsmanDJ, LiuPY (2010) Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets. Eur J Endocrinol 162:385–390
IshakKG, ZimmermanHJ (1987) Hepatotoxic effects of the anabolic-androgenic steroids. Semin Liver Dis 7:230–236
IsojarviJ (2008) Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms. Seizure 17:111–119
ItilTM, CoraR, AkpinarS, HerrmannWM, PattersonCJ (1974) “Psychotropic” action of sex hormones: computerized EEG in establishing the immediate CNS effects of steroid hormones. Curr Thera Res 16:1147–1170
ItilTM, MichaelST, ShapiroDM, ItilKZ (1984) The effects of mesterolone, a male sex hormone in depressed patients (a double blind controlled study. Methods Find Exp Clin Pharmacol 6:331–337
Jaime-PerezJC, Colunga-PedrazaPR, Gomez-RamirezCD, Gutierrez-AguirreCH, Cantu-RodriguezOG, Tarin-ArzagaLC, Gomez-AlmaguerD (2011) Danazol as first-line therapy for aplastic anemia. Ann Hematol 90:523–527
JaysonMI, HollandCD, KeeganA, IllingworthK, TaylorL (1991) A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis 50:41–47
JenkinsJS (1998) The voice of the castrato. Lancet 351:1877–1880
JeschkeMG, FinnertyCC, SumanOE, KulpG, MlcakRP, HerndonDN (2007) The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg 246:351–360; discussion:360–362
JockenhövelF, VogelE, ReinhardtW, ReinweinD (1997) Effects of various modes of androgen substitution therapy on erythropoiesis. Eur J Med Res 2:293–298
JohansenKL, MulliganK, SchambelanM (1999) Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA 281:1275–1281
KaltwasserJP, DixU, SchalkKP, VogtH (1988) Effect of androgens on the response to antithymocyte globulin in patients with aplastic anaemia. Eur J Haematol 40:111–118
KamischkeA, KemperDE, CastelMA, LuthkeM, RolfC, BehreHM, MagnussenH, NieschlagE (1998) Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 11:41–45
KassmannK, RappaportR, BroyerM (1992) The short-term effect of testosterone on growth in boys on hemodialysis. Clin Nephrol 37:148–154
KavanaghBP, McCowenKC (2010) Clinical practice. Glycemic control in the ICU. N Engl J Med 363:2540–2546
KennedyBJ, GilbertsenAS (1957) Increased erythropoiesis induced by androgenic hormone therapy. N Engl J Med 256:719–726
KennyAM, FabregasG, SongC, BiskupB, BellantonioS (2004) Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci 59:75–78
KennyAM, KleppingerA, AnnisK, RathierM, BrownerB, JudgeJO, McGeeD (2010) Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty. J Am Geriatr Soc 58:1134–1143
KentBD, MitchellPD, McNicholasWT (2011) Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 6:199–208
KerrebijnKF, DelverA (1969) Ethylestrenol (Orgabolin): effects on asthmatic children during corticosteroid treatment. Scand J Respir Dis 68:70–77
KimmelPL, MillerG, MendelsonWB (1989) Sleep apnea syndrome in chronic renal disease. Am J Med 86:308–314
KoYH, LewYM, JungSW, JoeSH, LeeCH, JungHG, LeeMS (2008) Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 28:375–383
KochakianCD (ed) (1976) Anabolic-Androgenic Steroids. Springer-Verlag, Berlin
KoperaH (1976) Miscellaneous uses of anabolic steroids. In: KochakianCD (ed) Anabolic-Androgenic Steroids. Springer-Verlag, Berlin, pp 535–625
KotlerDP, TierneyAR, WangJ, PiersonRN (1989) Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50:444–447
KraussDJ, TaubHA, LantingaLJ, DunskyMH, KellyCM (1991) Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence. J Urol 146:1566–1570
KrüskemperHL (1968) Anabolic Steroids. Academic Press, New York
KulkarniJ, de CastellaA, FitzgeraldPB, GurvichCT, BaileyM, BartholomeuszC, BurgerH (2008) Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 65:955–960
KulkarniJ, de CastellaA, HeadeyB, MarstonN, SinclairK, LeeS, GurvichC, FitzgeraldPB, BurgerH (2011) Estrogens and men with schizophrenia: is there a case for adjunctive therapy?Schizophr Res 125:278–283
LahitaRG, ChengCY, MonderC, BardinCW (1992) Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women. J Rheumatol 19:547–555
LakshmanKM, BasariaS (2009) Safety and efficacy of testosterone gel in the treatment of male hypogonadism. Clin Interv Aging 4:397–412
LangoucheL, van den BergheG (2006) The dynamic neuroendocrine response to critical illness. Endocrinol Metab Clin North Am 35:777–791, ix
LeBlancES, WangPY, JanowskyJS, NeissMB, FinkHA, YaffeK, MarshallLM, LapidusJA, StefanickML, OrwollES (2010) Association between sex steroids and cognition in elderly men. Clin Endocrinol (Oxf) 72:393–403
LeibenluftE, SchmidtPJ, TurnerEH, DanaceauMA, AshmanSB, WehrTA, RubinowDR (1997) Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men. J Clin Endocrinol Metab 82:3203–3207
LeleuX, TerriouL, DuhamelA, MoreauAS, AndrieuxJ, DupireS, CoiteuxV, BerthonC, MicolJB, GuiezeR, FaconT, BautersF (2006) Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens. Ann Hematol 85:711–716
LewisL, DahnM, KirkpatrickJR (1981) Anabolic steroid administration during nutritional support: a therapeutic controversy. J Parent Ent Nutr 5:64–66
Li BockE, FulleHH, HeimpelH, PribillaW (1976) Die Wirkung von Mesterolon bei Panmyelopathien und renalen Anaemien. Med Klin 71:539–547
LijesenGK, TheeuwenI, AssendelftWJ, Van Der WalG (1995) The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis. Br J Clin Pharmacol 40:237–243
LiuPY, DeathAK, HandelsmanDJ (2003a) Androgens and cardiovascular disease. Endocr Rev 24:313–340
LiuPY, YeeBJ, WishartSM, JimenezM, JungDG, GrunsteinRR, HandelsmanDJ (2003b) The short-term effects of high dose testosterone on sleep, breathing and function in older men. J Clin Endocrinol Metab 88:3605–3613
LiuPY, CatersonID, GrunsteinRR, HandelsmanDJ (2007) Androgens, obesity, and sleep-disordered breathing in men. Endocrinol Metab Clin North Am 36:349–363
LoprinziCL, KuglerJW, SloanJA, MailliardJA, KrookJE, WilwerdingMB, RowlandKM Jr, CamorianoJK, NovotnyPJ, ChristensenBJ (1999) Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 17:3299–3306
LovejoyJC, BrayGA, GreesonCS, KlempererM, MorrisJ, PartingtonC, TulleyR (1995) Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men. Int J Obes 19:614–624
LuPH, MastermanDA, MulnardR, CotmanC, MillerB, YaffeK, RebackE, PorterV, SwerdloffR, CummingsJL (2006) Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol 63:177–185
MacdonaldJH, MarcoraSM, JibaniMM, KumwendaMJ, AhmedW, LemmeyAB (2007) Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dose-finding study. Nephron Clin Pract 106:c125–c135
MaddreyWC (1986) Is therapy with testosterone or anabolic-androgenic steroids useful in the treatment of alcoholic liver disease?Hepatology 6:1033–1035
MakiPM, ErnstM, LondonED, MordecaiKL, PerschlerP, DursoSC, BrandtJ, DobsA, ResnickSM (2007) Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab 92:4107–4114
MaloiselF, AndresE, ZimmerJ, NoelE, ZamfirA, KoumarianouA, DufourP (2004) Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results. Am J Med 116:590–594
MandelliF, AmadoriS, DiniE, GrignaniF, LeoniP, LisoV, MartelliM, NeriA, PettiMC, FerriniPR (1981) Randomized clinical trial of immunotherapy and androgenotherapy for remission maintenance in acute non-lymphocytic leukemia. Leuk Res 5:447–452
MarinP (1995) Testosterone and regional fat distribution. Obes Res 3 Suppl 4:609S–612S
MarinP, HolmangS, JonssonL, SjostromL, KvistH, HolmG, LindstedtG, BjorntorpP (1992) The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes 16:991–997
MarinP, OdenB, BjorntorpP (1995) Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 80:239–243
MarwahaRK, BansalD, TrehanA, VarmaN (2004) Androgens in childhood acquired aplastic anaemia in Chandigarh, India. Trop Doct 34:149–152
McMullinGM, WatkinGT, Coleridge SmithPD, ScurrJH (1991) Efficacy of fibrinolytic enhancement with stanozolol in the treatment of venous insufficiency. Austr N Zealand Surgery 61:306–309
MendenhallCL, AndersonS, Garcia-PontP, GoldbergS, KiernanT, SeeffLB, SorrellM, TamburroC, WeesnerR, ZettermanR, ChedidA, ChenT, RabinL; Veterans Administration Cooperative Study on Alcoholic Hepatitis (1984) Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prenisolone. N Engl J Med 311:1464–1470
MendenhallCL, MoritzTE, RoselleGA, MorganTR, NemchauskyBA, TamburroCH, SchiffER, McClainCJ, MarsanoLS, AllenJI (1993) A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis. Hepatology 17:564–576
MillerJT, BtaicheIF (2009) Oxandrolone treatment in adults with severe thermal injury. Pharmacotherapy 29:213–226
MillmanRP, KimmelPL, ShoreET, WassersteinAG (1985) Sleep apnea in hemodialysis patients: the lack of testosterone effect on its pathogenesis. Nephron 40:407–410
MooradianAD, MorleyJE, KorenmanSG (1987) Biological actions of androgens. Endocr Rev 8:1–28
MullerM, van den BeldAW, van der SchouwYT, GrobbeeDE, LambertsSW (2006) Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men. J Clin Endocrinol Metab 91:3988–3991
MullerV, SzaboA, ViklickyO, GaulI, PortlS, PhilippT, HeemannUW (1999) Sex hormones and gender-related differences: their influence on chronic renal allograft rejection. Kidney Int 55:2011–2020
MulliganK, ZackinR, Von RoennJH, ChesneyMA, EgorinMJ, SattlerFR, BensonCA, LiuT, UmblejaT, ShriverS, AuchusRJ, SchambelanM (2007) Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. J Clin Endocrinol Metab 92:563–570
MurphyKD, ThomasS, MlcakRP, ChinkesDL, KleinGL, HerndonDN (2004) Effects of long-term oxandrolone administration in severely burned children. Surgery 136:219–224
NaikRB, GibbonsAR, GydeOH, HarrisBR, RobinsonBH (1978) Androgen trial in renal anaemia. Proc Eur Dial Transplant Assoc 15:136–143
NajeanY, PeckingA (1979) Refractory anemia with excess of blast cells: prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients. Cooperative Group for the Study of Aplastic and Refractory Anemias. Cancer 44:1976–1982
NajeanY; Joint Group for the Study of Aplastic and Refractory Anaemias (1981) Long-term follow-up in patients with aplastic anemia. A study of 137 androgen-treated patients surviving more than two years. Am J Med 71:543–551
NavarroJF, MoraC (2001) In-depth review effect of androgens on anemia and malnutrition in renal failure: implications for patients on peritoneal dialysis. Perit Dial Int 21:14–24
NavarroJF, MoraC, MaciaM, GarciaJ (2002) Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Kidney Int 61:1537–1544
NeffMS, GoldbergJ, SlifkinRF, EiserAR, CalamiaV, KaplanM, BaezA, GuptaS, MattooN (1981) A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med 304:871–875
NeffMS, GoldbergJ, SlifkinRF, EiserAR, CalamiaV, KaplanM, BaezA, GuptaS, MattooN (1985) Anemia in chronic renal failure. Acta Endocrinol Suppl 271:80–86
NicolodiM, SicuteriF, PoggioniM (1993a) Hypothalamic modulation of nociception and reproduction in cluster headache. I. Therapeutic trials of leuprolide. Cephalgia 13:253–257
NicolodiM, SicuteriF, PoggioniM (1993b) Hypothalamic modulation of nociception and reproduction in cluster headache. II. Testosterone-induced increase of sexual activity in males with cluster headache. Cephalgia 13:258–260
NieschlagE, CuppersHJ, WickingsEJ (1977) Influence of sex, testicular development and liver function on the bioavailability of oral testosterone. Eur J Clin Invest 7:145–147
NieschlagE, NieschlagS, BehreHM (1993) Lifespan and testosterone. Nature 366:215
NordmarkG, BengtssonC, LarssonA, KarlssonFA, SturfeltG, RonnblomL (2005) Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Autoimmunity 38:531–540
O'ConnellMD, TajarA, RobertsSA, WuFC (2011) Do androgens play any role in the physical frailty of ageing men?Int J Androl 34:195–211
OkunMS, FernandezHH, RodriguezRL, RomrellJ, SuelterM, MunsonS, LouisED, MulliganT, FosterPS, ShenalBV, ArmaghaniSJ, JacobsonC, WuS, CrucianG (2006) Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Arch Neurol 63:729–735
OrrR, Fiatarone SinghM (2004) The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. Drugs 64:725–750
PaeCU (2009) Comments on “Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial” by Dr Ko and colleagues. J Clin Psychopharmacol 29:194–195; author reply:196–197
PalaciosA, CampfieldLA, McClureRD, SteinerB, SwerdloffRS (1983) Effect of testosterone enanthate on hematopoesis in normal men. Fertil Steril 40:100–104
ParsadD, PandhiR, JunejaA (2001) Stanozolol in chronic urticaria: a double blind, placebo controlled trial. J Dermatol 28:299–302
PhillipsEH, RyanS, FerrariR, GreenC (2003) Estratest and Estratest HS (esterified estrogens and methyltestosterone) therapy: a summary of safety surveillance data, January 1989 to August 2002. Clin Ther 25:3027–3043
PopeHG Jr, AmiazR, BrennanBP, OrrG, WeiserM, KellyJF, KanayamaG, SiegelA, HudsonJI, SeidmanSN (2010) Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol 30:126–134
PortierF, PortmannA, CzernichowP, VascautL, DevinE, BenhamouD, CuvelierA, MuirJF (2000) Evaluation of home versus laboratory polysomnography in the diagnosis of sleep apnea syndrome. Am J Respir Crit Care Med 162:814–818
PourmandG, SalemS, KaramiA, BaradaranN, MehrsaiA (2008) Anabolic-androgenic steroid effects on early morbid symptoms after open prostatectomy: a pilot study. Aging Male 11:123–127
PrzkoraR, HerndonDN, SumanOE (2007) The effects of oxandrolone and exercise on muscle mass and function in children with severe burns. Pediatrics 119:e109–e116
QuigleyCA, DeBellisA, MarschkeKB, El-AwadyMK, WilsonEM, FrenchFF (1995) Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev 16:271–321
RabkinJG, WagnerGJ, RabkinR (1999) Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. J Clin Psychopharmacol 19:19–27
RabkinJG, McElhineyMC, RabkinR, McGrathPJ, FerrandoSJ (2006) Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am J Psychiatry 163:59–66
RambaldiA, GluudC (2006) Anabolic-androgenic steroids for alcoholic liver disease. Cochrane Database Syst Rev 4:CD003045
ReckelhoffJF, YanesLL, IliescuR, FortepianiLA, GrangerJP (2005) Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol 289:F941–F948
ReidIR, WattieDJ, EvansMC, StapletonJP (1996) Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 156:1173–1177
ReillyJT (2006) Idiopathic myelofibrosis: pathogenesis to treatment. Hematol Oncol 24:56–63
RiceL (2004) Danazol, idiopathic thrombocytopenic purpura, and thrombopoietin. Am J Med 117:972–973; author reply:973
RiedlM, GowerRG, ChrvalaCA (2011) Current medical management of hereditary angioedema: results from a large survey of US physicians. Ann Allergy Asthma Immunol 106:316–322.e4
SandblomRE, MatsumotoAM, ScoeneRB, LeeKA, GiblinEC, BremnerWJ, PiersonDJ (1983) Obstructive sleep apnea induced by testosterone administration. N Engl J Med 308:508–510
SardarP, JhaA, RoyD, MajumdarU, GuhaP, RoyS, BanerjeeR, BanerjeeAK, BandyopadhyayD (2010) Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial. HIV Clin Trials 11:220–229
SattlerFR, JaqueSV, SchroederET, OlsonC, DubeMP, MartinezC, BriggsW, HortonR, AzenS (1999) Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus. J Clin Endocrinol Metab 84:1268–1276
SaylorPJ, SmithMR (2010) Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer. J Natl Compr Canc Netw 8:211–223
SchneiderBK, PickettCK, ZwillichCW, WeilJV, McDermottMT, SantenRJ, VaranoLA, WhiteDP (1986) Influence of testosterone on breathing during sleep. J Appl Physiol 61:618–623
SchofieldRS, HillJA, McGinnCJ, ArandaJM (2002) Hormone therapy in men and risk of cardiac allograft rejection. J Heart Lung Transplant 21:493–495
ScholsAM, SoetersPB, MostertR, PluymersRJ, WoutersEF (1995) Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 152:1268–1274
ScholsAM, SlangenJ, VolovicsL, WoutersEF (1998) Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1791–1797
ScottJD, WolfePR, AndersonP, CohanGR, ScarsellaA (2007) Prospective study of topical testosterone gel (AndroGel) versus intramuscular testosterone in testosterone-deficient HIV-infected men. HIV Clin Trials 8:412–420
SeidmanSN, OrrG, RavivG, LeviR, RooseSP, KravitzE, AmiazR, WeiserM (2009) Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trialJ Clin Psychopharmacol 29:216–221
ShahidiNT (1973) Androgens and erythropoiesis. N Engl J Med 289:72–80
SharmaS, ArnejaA, McLeanL, DuerksenD, LeslieW, SciberrasD, LertzmanM (2008) Anabolic steroids in COPD: a review and preliminary results of a randomized trial. Chron Respir Dis 5:169–176
ShefferAL, FearonDT, AustenKF (1977) Methyltestosterone therapy in hereditary angioedema. Ann Intern Med 86:306–308
SicotteNL, GiesserBS, TandonV, KlutchR, SteinerB, DrainAE, ShattuckDW, HullL, WangHJ, ElashoffRM, SwerdloffRS, VoskuhlRR (2007) Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol 64:683–688
SiddiqueH, SmithJC, CorrallRJ (2004) Reversal of polycythaemia induced by intramuscular androgen replacement using transdermal testosterone therapy. Clin Endocrinol (Oxf) 60:143–145
SilverbergD, WexlerD, BlumM, SchwartzD, IainaA (2004) The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure. Nephrol Dial Transplant 19:1021
SinghAB, NorrisK, ModiN, Sinha-HikimI, ShenR, DavidsonT, BhasinS (2001) Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men. J Clin Endocrinol Metab 86:2437–2445
SloaneDE, LeeCW, ShefferAL (2007) Hereditary angioedema: safety of long-term stanozolol therapy. J Allergy Clin Immunol 120:654–658
SnyderPJ, PeacheyH, HannoushP, BerlinJA, LohL, LenrowDA, HolmesJH, DlewatiA, SantannaJ, RosenCJ, StromBL (1999) Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647–2653
SpauldingWB (1960) Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann Intern Med 53:739–745
SpiersASD, DeVitaSF, AllarMJ, RichardsS, SedranakN (1981) Beneficial effects of an anabolic steroid during cytotoxic chemotherapy for metatstatic cancer. J Med 12:433–446
Srinivas-ShankarU, RobertsSA, ConnollyMJ, O'ConnellMD, AdamsJE, OldhamJA, WuFC (2010) Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 95:639–650
StennerJ, HolthausK, MackenzieSH, CrawfordED (1998) The effect of ejaculation on prostate-specific antigen in a prostate cancer-screening population. Urology 51:455–459
StrawfordA, BarbieriT, Van LoanM, ParksE, CatlinD, BartonN, NeeseR, ChristiansenM, KingJ, HellersteinMK (1999) Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA 281:1282–1290
SullivanDH, RobersonPK, JohnsonLE, BisharaO, EvansWJ, SmithES, PriceJA (2005) Effects of muscle strength training and testosterone in frail elderly males. Med Sci Sports Exerc 37:1664–1672
SvartbergJ (2010) Androgens and chronic obstructive pulmonary disease. Curr Opin Endocrinol Diabetes Obes 17:257–261
SvartbergJ, AaseboU, HjalmarsenA, SundsfjordJ, JordeR (2004) Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial. Respir Med 98:906–913
TalbotJA, SheldrickR, CaswellH, DuncanS (2008) Sexual function in men with epilepsy: how important is testosterone?Neurology 70:1346–1352
TeruelJL, MarcenR, NavarroJF, VillafruelaJJ, Fernandez-LucasM, LianoF, OrtunoJ (1995) Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study. Nephron 70:282–286
TeruelJL, AguileraA, MarcenR, AntolinJN, OteroGG, OrtunoJ (1996a) Androgen therapy for anaemia of chronic renal failure. Scand J Urol Nephr 30:403–408
TeruelJL, MarcenR, Navarro-AntolinJ, AguileraA, Fernandez-JuarezG, OrtunoJ (1996b) Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study. J Am Soc Nephrol 7:140–144
TeruelJL, CanoT, MarcenR, VillafruelaJJ, RiveraM, Fernandez-JuarezG, OrtunoJ (1997) Decrease in the haemoglobin level in haemodialysis patients undergoing antiandrogen therapy. Nephro Dial Transplant 12:1262–1263
ThomasS, WolfSE, MurphyKD, ChinkesDL, HerndonDN (2004) The long-term effect of oxandrolone on hepatic acute phase proteins in severely burned children. J Trauma 56:37–44
TweedleD, WaltonC, JohnstonIDA (1973) The effect of an anabolic steroid on postoperative nitrogen balance. Br J Clin Pract 27:130–132
VACURG (Veterans Administration Cooperative Urological Research Group) (1967) Carcinoma of the prostate: treatment comparisons. J Urol 98:516–522
van CoevordenA, StolearJC, DhaeneM, van HerweghemJL, MockelJ (1986) Effect of chronic oral testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients. Clin Nephrol 26:48–54
van den BergheG, WoutersP, WeekersF, VerwaestC, BruyninckxF, SchetzM, VlasselaersD, FerdinandeP, LauwersP, BouillonR (2001) Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 345:1359–1367
Van VollenhovenRF, EnglemanEG, McGuireJL (1995) Dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 38:1826–1831
VaughanC, GoldsteinFC, TenoverJL (2007) Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone. J Androl 28:875–882
VecchioM, NavaneethanSD, JohnsonDW, LucisanoG, GrazianoG, SaglimbeneV, RuospoM, QuerquesM, JanniniEA, StrippoliGF (2010) Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst Rev 12:CD007747
VelazquezI, AlterBP (2004) Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 77:257–267
VictorG, ShanmugasundaramK, KrishnamurthiCA, RexPM, NagarajanD (1967) Haemoglobin response to anabolic steroid in iron-deficiency anaemia. J Assoc Physicians India 15:177–183
VillarealDT, MorleyJE (1994) Trophic factors in aging. Should older people receive hormonal replacement therapy?Drugs Aging 4:492–509
von HartitzschB, KerrDNS (1976) Response to parenteral iron with and without androgen therapy in patients undergoing regular haemodialysis. Nephron 17:430–438
WaltersKA, SimanainenU, HandelsmanDJ (2010) Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. Hum Reprod Update 16:543–558
WarrenMF, SerbyMJ, RoaneDM (2008) The effects of testosterone on cognition in elderly men: a review. CNS Spectr 13:887–897
WatsonRN, BradleyMH, CallahanR, PetersBJ, KoryRC (1959) A six-month evaluation of an anabolic drug, norethandrolone, in underweight persons. Am J Med 26:238–248
WattelE, CambierN, CaulierMT, SautiereD, BautersF, FenauxP (1994) Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases. Br J Haematol 87:205–208
WebbWR, DoyleRS, HowardHS (1960) Relative metabolic effects of calories, protein, and an anabolic steroid (19-nortestosterone) in early postoperative period. Metabolism 9:1047–1057
WeberJP, WalshPC, PetersCA, SpivakJL (1991) Effect of reversible androgen deprivation on hemoglobin and serum erythropoietin in men. Am J Hematol 36:190–194
WellsR (1960) Prednisolone and testosterone propionate in cirrhosis of the liver: a controlled trial. Lancet 2:1416–1419
WhitnallMH, ElliottTB, HardingRA, InalCE, LandauerMR, WilhelmsenCL, McKinneyL, MinerVL, JacksonWE 3rd, LoriaRM, LedneyGD, SeedTM (2000) Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. Int J Immunopharmacol 22:1–14
WilkeyJL, BarsonLJ, KestL, BragagniA (1960) The effect of testosterone on the azotemic patient: an intermediary report. J Urol 83:25–29
WilliamsJS, SteinJH, FerrisTF (1974) Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study. Arch Intern Med 134:289–292
WinearlsCG (1995) Historical review of the use of recombinant human erythropoietin in chronic renal failure. Nephrol Dial Transplant 10 (Suppl 2):3–9
WolfSE, EdelmanLS, KemalyanN, DonisonL, CrossJ, UnderwoodM, SpenceRJ, NoppenbergerD, PalmieriTL, GreenhalghDG, LawlessM, VoigtD, EdwardsP, WarnerP, KaganR, HatfieldS, JengJ, CreanD, HuntJ, PurdueG, BurrisA, CairnsB, KesslerM, KleinRL, BakerR, YowlerC, TutuloW, FosterK, CarusoD, HildebrandB, BenjaminW, VillarrealC, SanfordAP, SaffleJ (2006) Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. J Burn Care Res 27:131–139; discussion:140–141
WuFC, von EckardsteinA (2003) Androgens and coronary artery disease. Endocr Rev 24:183–217
WuFCW, FarleyTMM, PeregoudovA, WaitesGMH; WHO Task Force on Methods for the Regulation of Male Fertility (1996) Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. Fertil Steril 65:626–636
WulfsohnNL, PolitzerWM, HenricoJS (1964) Testosterone therapy in bronchial asthma. S Afr Med J 38:170–172
YoungGA, YuleAG, HillGL (1983) Effects of an anabolic steroid on plasma amino acids, proteins, and body composition in patients receiving intravenous hyperalimentation. J Parent Ent Nutr 7:221–225
YoungLA, NeissMB, SamuelsMH, RoselliCE, JanowskyJS (2010) Cognition is not modified by large but temporary changes in sex hormones in men. J Clin Endocrinol Metab 95:280–288
YoungN, GriffithP, BrittainE, ElfenbeinG, GardnerF, HuangA, HarmonD, HewlettJ, FayJ, ManganK (1988) A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood 72:1861–1869
YoungRL, FuchsRJ, WoltjenMJ (1976) Chorionic gonadotropin in weight control. A double-blind crossover study. JAMA 236:2495–2497
ZakPJ, KurzbanR, AhmadiS, SwerdloffRS, ParkJ, EfremidzeL, RedwineK, MorganK, MatznerW (2009) Testosterone administration decreases generosity in the ultimatum game. PLoS One 4:e8330
ZarroufFA, ArtzS, GriffithJ, SirbuC, KommorM (2009) Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 15:289–305
ZawilskaK, TokarzA, MisiakA, PsujaP, WislawskiS, SzymczakP, MeissnerJ, KaronJ, LewandowskiK, LopaciukS, ZiemskiJM, SowlerJ (1990) Nebulised heparin and anabolic steroid in the prevention of postoperative deep venous thrombosis following elective abdominal surgery. Folia Haematologica 117:699–707